Yazar "Yılmaz, Yusuf" için TR-Dizin İndeksli Yayınlar Koleksiyonu listeleme
-
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Feng, Gong; Valenti, Luca; Wong, Vincent Wai-Sun; Fouad, Yasser Mahrous; Yılmaz, Yusuf; Kim, Won; Sebastiani, Giada; Younossi, Zobair M.; Hernandez Gea, Virginia; Zheng, Ming-Hua (SpringerNature, 2023)Recompensation has gained increasing attention in the feld of cirrhosis, particularly in chronic liver disease with a defnite aetiology. The current global prevalence of obesity and nonalcoholic fatty liver disease (NAFLD) ... -
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients
Ergenç, İlkay; Gözaydınoğlu, Büşra; Keklikkıran, Çağlayan; Yılmaz, Yusuf (Kare Publishing, 2023)Background and Aim: This study investigated the risk of the development of primary biliary cholangitis (PBC) in individuals who were incidentally identified as having positive antimitochondrial antibodies (AMA)-M2.Materials ... -
The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
Yılmaz, Yusuf; Kaya, Eda (Kare Publishing, 2023)Among chronic liver conditions, metabolic (dysfunction)-associated fatty liver disease (MAFLD) ranks as the most frequent. With a worldwide prevalence of 37%, the global burden of MAFLD is large and growing. -
The role of the systemic immune-inflammation index in predicting response to cardiac resynchronization therapy
Çelik, Mehmet; Küp, Ayhan; Demir, Serdar; Gülşen, Kamil; İzci, Servet; Yılmaz, Ahmet Seyda; Yılmaz, Yusuf; Çelik, Fatma Betül; Kahraman, Fatih; Tanırcan, Muhammed Raşit (2022)Aim: Cardiac resynchronization therapy (CRT) is a reliable treatment modality in patients with systolic dysfunction. However, not every patient appears to benefit from CRT. The systemic immune inflammation index (SII) ... -
TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease
Yılmaz, Yusuf; Zeybel, Müjdat; Adalı, Gupse; Coşar, Arif Mansur; Sertesen, Elif; Gökcan, Hale; Bahçecioğlu, Halil İbrahim; Şahin, Mustafa; Tulunay, Cansın; Ergun, İhsan; Turan, İlker; İdilman, İlkay Sedatak; Çelikel, Çiğdem; Kırımlıoğlu, Hale; Akyol, Gülen; Yılmaz, Funda; Sökmensuer, Cenk; Güveli, Hakan; Akarca, Ulus Salih; Akyüz, Ümit; Genç, Volkan; Akyıldız, Murat; Yazıhan, Nuray; Tutar, Engin; Ateş, Fehmi; Dinçer, Dinç; Balaban, Yasemin; Kıyıcı, Murat; Akdoğan, Meral; Sonsuz, Abdullah; İdilman, Ramazan (Kare Publishing, 2023)Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become ...